The Leading Cardiomyocyte Assay
for safety and efficacy
Clinically Relevant
Measures and interprets drug effects on cardiac cell function at clinically relevant doses
Eliminates Risk
Our unique technology is designed to eliminate risk at an earlier stage in development
Three-in-One
The only assay to simultaneously measure voltage, calcium, and contractility in the same cells
The CellOPTIQ® Platform
One assay. Same Cells. Comprehensive & Consistent Data.
The CellOPTIQ assay simultaneously measures voltage, calcium and contractility in the same cells
Applications
Cardiac Safety
The reliable, robust and predictive cardiomyocyte safety assay for identifying a broad spectrum of cardiovascular liabilities.
Cardiac Drug Discovery
Comprehensive measurement of voltage, calcium and contractility for heart failure efficacy studies
Extensively Validated
Featured News
Start a study with Clyde
Clyde’s CellOPTIQ® has helped many of the world's best pharma companies solve complex problems more effectively and less expensively than doing so in-house.
Whether you have a current cardiovascular issue or alternatively would like to prevent late stage failures Clyde can help.
Most of our standard studies are completed within 2 weeks.
To enquire about how Clyde could help with your project complete the enquiry form below and we’ll be get back to you as soon as we can. Alternatively email us at info@clydebio.com